trial · primary record
Bicalutamide
Non-Muscle Invasive Bladder Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 160 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Rate of bladder tumour recurrence |
| Registry ID | NCT05327647 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:23.042Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05327647
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.